Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?

References

• Agirre M, Zarate J, Puras G, et al. (2015). Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification. Drug Deliv 22:100–10
   PubMed Web of Science ®Google Scholar
• Anirudhan TS., Binusreejayan (2016). Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells. Int J Biol Macromol 88:222–35
   PubMed Web of Science ®Google Scholar
• Barbu E, Molnàr E, Tsibouklis J, et al. (2009). The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier. Expert Opin Drug Deliv 6:553–65
   PubMed Web of Science ®Google Scholar
• Boyles MS, Kristl T, Andosch A, et al. (2015). Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum components. J Nanobiotechnol 13:84
   PubMed Web of Science ®Google Scholar
• Carbone C, Campisi A, Musumeci T, et al. (2014). FA-loaded lipid drug delivery systems: preparation, characterization and biological studies. Eur J Pharm Sci 52:12–20
   PubMed Web of Science ®Google Scholar
• Chen Z, Lai X, Song S, et al. (2016). Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy. Drug Deliv 23:1369–73
   PubMed Web of Science ®Google Scholar
• Chekhonin VP, Baklaushev VP, Yusubalieva GM, et al. (2012). Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43. Nanomedicine 8:63–70
   PubMed Web of Science ®Google Scholar
• Chinaeke EE, Chime SA, Onyishi VI, et al. (2015). Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids. Drug Deliv 22:652–65
   PubMed Web of Science ®Google Scholar
• Feng R, Zhang Z, Li Z, et al. (2014). Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Drug Deliv 21:185–92
   PubMed Web of Science ®Google Scholar
• Frungillo L, Martins D, Teixeira S, et al. (2009). Targeted antitumoral dehydrocrotonin nanoparticles with L-ascorbic acid 6-stearate. J Pharm Sci 98:4796–807
   PubMed Web of Science ®Google Scholar
• Gaba B, Fazil M, Ali A, et al. (2015). Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Deliv 22:691–700
   PubMed Web of Science ®Google Scholar
• Gao H, Yang Z, Cao S, et al. (2014). Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Biomaterial 35:2374–82
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhang C, Zhou Y, et al. (2015). Endosomal pH-responsive polymer-based dual-ligand-modified micellar nanoparticles for tumor targeted delivery and facilitated intracellular release of paclitaxel. Pharm Res 32:2649–62
   PubMed Web of Science ®Google Scholar
• Gastaldi L, Battaglia L, Peira E, et al. (2014). Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art. Eur J Pharm Biopharm 87:433–44
   PubMed Web of Science ®Google Scholar
• Hejri A, Khosravi A, Gharanjig K, et al. (2013). Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. Food Chem 141:117–23
   PubMed Web of Science ®Google Scholar
• Hou LC, Veeravagu A, Hsu AR, et al. (2006). Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 20:E5
   PubMedGoogle Scholar
• Huang G, Zhang N, Bi X, et al. (2008). Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. Int J Pharm 355:314–20
   PubMed Web of Science ®Google Scholar
• Jain KK. (2010). Advances in the field of nanooncology. BMC Med 8:83
   PubMed Web of Science ®Google Scholar
• Khan AW, Kotta S, Ansari SH, et al. (2015). Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv 22:552–61
   PubMed Web of Science ®Google Scholar
• Kim SS, Harford JB, Pirollo KF, et al. (2015). Effective treatment of glioblastoma requires crossing the blood–brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine. Biochem Biophys Res Commun 468:485–9
   PubMed Web of Science ®Google Scholar
• Kumar A, Ahuja A, Ali J, et al. (2016). Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells. Drug Deliv 23:214–29
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao D, Zhang X, et al. (2016). Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes. Mater Sci Eng C Mater Biol Appl 64:124–32
   PubMed Web of Science ®Google Scholar
• Martins SM, Sarmento B, Nunes C, et al. (2013). Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Eur J Pharm Biopharm 85:488–502
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
   PubMed Web of Science ®Google Scholar
• Müller RH, Shegokar R, Keck CM. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol 8:207–27
   PubMedGoogle Scholar
• Puglia C, Offerta A, Tirendi GG, et al. (2016). Design of solid lipid nanoparticles for caffeine topical administration. Drug Deliv 23:36–40
   PubMed Web of Science ®Google Scholar
• Shi F, Yang G, Ren J, et al. (2013). Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers. Int J Nanomedicine 8:2533–41
   PubMed Web of Science ®Google Scholar
• Song S, Mao G, Du J, et al. (2016). Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Drug Deliv 23:1404–8
   PubMed Web of Science ®Google Scholar
• Tian XH, Lin XN, Wei F, et al. (2011). Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomedicine 6:445–52
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pathak K. (2011). Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 415:232–43
   PubMed Web of Science ®Google Scholar
• Wang T, Zhao P, Zhao Q, et al. (2016). The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier. Drug Deliv 23:420–8
   PubMed Web of Science ®Google Scholar
• Wang W, Zhou F, Ge L, et al. (2012). Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomedicine 7:2513–22
   PubMed Web of Science ®Google Scholar
• Wang Y, Li P, Chen L, et al. (2015). Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Drug Deliv 22:191–8
   PubMed Web of Science ®Google Scholar
• Woodworth GF, Dunn GP, Nance EA, et al. (2014). Emerging insights into barriers to effective brain tumor therapeutics. Front Oncol 4:126
   PubMedGoogle Scholar
• Wu M, Fan Y, Lv S, et al. (2015). Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Drug Deliv 1–6
   Web of Science ®Google Scholar
• Zhang B, Sun X, Mei H, et al. (2013). LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Biomaterials 34:9171–82
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Liu T, et al. (2016). Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer. Drug Deliv 23:794–800
   PubMed Web of Science ®Google Scholar
• Zou W, Cao G, Xi Y, et al. (2009). New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles. Drug Deliv 16:15–23
   PubMed Web of Science ®Google Scholar